BCG infection dose guides dendritic cell migration and T cell priming in the draining lymph node
Scandinavian Journal of Immunology · 2024
DOI: 10.1111/sji.13342 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scandinavian Journal of Immunology, 2024. Verfasst von Veronika Krmeská und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: T-Lymphocytes, BCG Vaccine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Instituto Carlos Chagas, Fundação Oswaldo Cruz, Karolinska Institutet.
Abstract (Originalsprache)
In contrast to delayed‐type hypersensitivity (DTH) and other hallmark reactions of cell‐mediated immunity that correlate with vaccine‐mediated protection against Mycobacterium tuberculosis , the contribution of vaccine dose on responses that emerge early after infection in the skin with Bacille Calmette–Guérin (BCG) is not well understood. We used a mouse model of BCG skin infection to study the effect of BCG dose on the relocation of skin Dendritic cells (DCs) to draining lymph node (DLN). Mycobacterium antigen 85B‐specific CD4 + P25 T cell‐receptor transgenic (P25 TCRTg) cells were used to probe priming to BCG in DLN. DC migration and T cell priming were studied across BCG inocula that varied up to 100‐fold (10 4 to 10 6 Colony‐forming units—CFUs). In line with earlier results in guinea pigs, DTH reaction in our model correlated with BCG dose. Importantly, priming of P25 TCRTg cells in DLN also escalated in a dose‐dependent manner, peaking at day 6 after infection. Similar dose‐escalation effects were seen for DC migration from infected skin and the accompanying transport of BCG to the DLN. BCG‐triggered upregulation of co‐stimulatory molecules on migratory DCs was restricted to the first 24 hour after infection and was independent of BCG dose over a 10‐fold range (10 5 to 10 6 CFUs). The dose seemed to be a determinant of the number of total skin DCs that move to the DLN. In summary, our results support the use of higher BCG doses to detect robust DC migration and T cell priming.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden.
- Instituto Carlos Chagas, Fundação Oswaldo Cruz (ICC/Fiocruz-PR), Curitiba, Brazil.
ORCID-Profile: Veronika Krmeská, Antonio Gigliotti Rothfuchs
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Instituto Carlos Chagas, Fundação Oswaldo Cruz
- Karolinska Institutet
- Vetenskapsrådet
Zitieren
APA
Krmeská, V., Shen, L., Nylén, S., Wowk, P. F., & Rothfuchs, A. G. (2024). BCG infection dose guides dendritic cell migration and T cell priming in the draining lymph node. Scandinavian Journal of Immunology. https://doi.org/10.1111/sji.13342
Vancouver
Krmeská V, Shen L, Nylén S, Wowk PF, Rothfuchs AG. BCG infection dose guides dendritic cell migration and T cell priming in the draining lymph node. Scandinavian Journal of Immunology. 2024. doi:10.1111/sji.13342
BibTeX
@article{Krmesk2024,
author = {Krmeská, Veronika and Shen, Lei and Nylén, Susanne and Wowk, Pryscilla Fanini and Rothfuchs, Antonio Gigliotti},
title = {BCG infection dose guides dendritic cell migration and T cell priming in the draining lymph node},
journal = {Scandinavian Journal of Immunology},
year = {2024},
doi = {10.1111/sji.13342}
}
EUVIMED